CASE REPORT
Complex grade III astrocytoma with granular cells and PXA features in a patient with tuberous sclerosis complex (Bourneville-Pringle syndrome) – case report and review of literature
1
Department of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, Poland
2
Department of Radiotherapy for Children and Adults, University Children’s Hospital of Krakow, Poland
3
Jagiellonian University in Cracow, Faculty of Health Sciences, Krakow, Poland
4
Amethyst Radiotherapy Poland, Krakow, Poland
5
Department of Pathology, Jagiellonian University Medical College, Krakow, Poland
6
Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland
7
Department of Tumour Pathology, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, Poland
8
Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, Poland
9
Gynecologic Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, Poland
10
I Radiation and Clinical Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland
Publication date: 2021-09-30
Pol J Pathol 2021;72(2):180-184
KEYWORDS
pleomorphic xanthoastrocytomatuberous sclerosis complexBourneville-Pringle syndromesurgeryradiotherapy
ABSTRACT
Tuberous sclerosis complex (Bourneville-Pringle syndrome) is a rare genetic condition included in the group of diseases called phakomatoses. Most of the patients are diagnosed with abnormalities within the central nervous system and tend to develop tumors more frequently, especially gliomas. We present a case of 50-year-old patient suffering from tuberous sclerosis complex, who had been diagnosed with pleomorphic xanthoastrocytoma (PXA). The patient underwent surgery and adjuvant radiotherapy and has remained free from local recurrence for 5 years.
REFERENCES (19)
1.
Peron A, Northrup H. Tuberous sclerosis complex. Am J Med Genet Part C 2018; 178C: 274-277.
2.
Brigo F, Lattanzi S, Trinka E, et al. First descriptions of tuberous sclerosis by Désiré-Magloire Bourneville (1840-1909). Neuropathology 2018; 38: 577-582.
3.
O’Callaghan FJ, Shiell AW, Osborne JP, Martyn CN. Prevalence of tuberous sclerosis estimated by capture – recapture analysis. Lancet 1998; 351: 1490.
4.
Caban C, Khan N, Hasbani DM, Crino PB. Genetics of tuberous sclerosis complex: implications for clinical practice. Appl Clin Genet 2016; 10: 1-8.
5.
Strowd RE, Strowd LC, Blakeley JO. Cutaneous manifestations in neuro-oncology: clinically relevant tumor and treatment associated dermatologic findings. Semin Oncol 2016; 43: 401-407.
6.
Dallos G, Chmel R, Alfoldy F, et al. Bourneville-Pringle disease for kidney transplantation: a single-center experience. Transplant Proc 2006; 38: 2823-2824.
7.
Crino PB, Nathanson KL, Henske EP. Medical Progress: The Tuberous Sclerosis Complex. N Eng J Med 2006; 355: 1345-1356.
8.
Martinez-Garcia A, Michel-Macias C, Cordero-Gonzalez G, et al. Giant left ventricular rhabdomyoma treated successfully with everolimus: case report and review of literature. Cardiol Young 2018; 15: 1-7.
9.
Gupta N, Henske EP. Pulmonary manifestations in tuberous sclerosis complex. Am J Med Genet Part C 2018; 178C: 326-337.
10.
Curatolo P, Moavero R, de Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol 2015; 14: 733-745.
11.
Lu DS, Karas PJ, Krueger DA, Weiner HL. Central nervous system manifestations of tuberous sclerosis complex. Am J Med.
13.
Northrup H, Krueger DA; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 2013; 49: 243-254.
14.
Zorzi F, Facchetti F, Baronchelli C, Cani E. Pleomorphic xanthoastrocytoma: an immunohistochemical study of three cases. Histopathology 1992; 20: 267-269.
15.
Loiseau H, Rivel J, Vital C, et al. Pleomorphic xanthoastrocytoma: Apropos of 3 new cases. Review of the literature. Neurochir 1991; 37: 338-347.
16.
Naidich MJ, Walker MT, Gottardi-Littell NR, et al. Cerebellum pleomorphic xanthoastrocytoma in a patient with neurofibromatosis type 1. Neuroradiology 2004; 46: 825-829.
17.
Gil-Gouveia R, Cristino N, Farias JP, et al. Pleomorphic xanthoastrocytoma of the cerebellum: illustrated review. Acta Neurochir 2004; 146: 1241-1244.
18.
Kepes JJ, Rubinstein LJ, Eng LF. Pleomorphic xanthoastrocytoma: a distinctive meningocerebral glioma of young subjects with relatively favorable prognosis. A study of 12 cases. Cancer 1979; 44: 1839-1852.
19.
Giannini C, Scheithauer BW, Burger PC, et al. Pleomorphic xanthoastrocytoma. What Do We Really Know about It? Cancer 1999; 85: 2033-45.
Share
RELATED ARTICLE
| eISSN: | 2084-9869 |
| ISSN: | 1233-9687 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
